A blood-based epigenetic clock for kidney health
Kilder
- Nature: A blood-based epigenetic clock for intrinsic capacity predicts mortality and is associated with clinical, immunological and lifestyle factors - Nature
- Nature: Genomics of host–microbiome interactions in humans - Nature
- Nature: How a mysterious epidemic of kidney disease is killing thousands of young men - Nature
- Fiercebiotech: Bayer's Vividion secures rights to only clinical-stage covalent WRN inhibitor from partner Roche - Fierce Biotech
- Biopharmadive: FDA to use new review tool on Sarepta’s gene therapy work - BioPharma Dive
- Bioworld: Sarepta’s gene therapy gets boost with FDA platform designation - BioWorld MedTech
Oppsummeringen og talen er laget med KI. Kildelenkene viser opphavet og er ikke en anbefaling av TellMe fra mediene.